This happens because glucose changes affect the lens of the eye, altering its refractive properties
doi: 10.1007/s00125-020-05375-2
This is likely due to greater weight loss seen in this trial, approximately 21% with 15 mg dosing, far exceeding the 14% weight loss observed in GLP-1 RA trials [14, 16, 19, 20, 23]
You may notice quieter cravings, smaller meals, or more stable energy before weight changes show up
Instead, risk reductions were similar across the BMI spectrum
One of them is Akkermansia muciniphila a "highly-promising" probiotic with the potential to help prevent and treat obesity and diabetes, according to a 2017 study potential being a key word here